Answers are grounded in this paper and cite their sources.
Shows astaxanthin pre-treatment reduces heart injury after liver transplantation in rats, indicating therapeutic potential through the Nrf2/HO-1 pathway.
This study investigated astaxanthin's cardioprotective effects in rat autologous orthotopic liver transplantation. Male Wistar rats received astaxanthin (500 mg/kg) for two weeks before transplantation, with controls including sham, transplant-only, and astaxanthin plus all-trans retinoic acid groups. Astaxanthin pre-conditioning significantly reduced myocardial injury markers: IL-6 decreased 2.3-fold, cTnI decreased 1.8-fold, and TNF-α decreased 2.1-fold versus transplant controls. SOD activity increased 1.6-fold while MDA levels decreased 2.4-fold. The Bcl-2/Bax ratio improved 2.2-fold. All-trans retinoic acid negated these protective effects. Astaxanthin pre-conditioning alleviated myocardial injury via the Nrf2/HO-1 pathway, demonstrating therapeutic potential for cardiac protection during liver transplantation.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: